跳至主要内容
临床试验/NL-OMON51095
NL-OMON51095招募中不适用

Fear of progression in advanced cancer patients with prolonged survival on ongoing cancer treatment in an era of personalized medicine - PERSPECTIVES

niversitair Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult patients with any type of advanced/metastasized/incurable cancer;
  • Receiving (ongoing) palliative systemic treatment (chemotherapy, hormonal
  • therapy, targeted therapy, immunotherapy);
  • Prognosis > 12 months;
  • Able to fill in digital questionnaires;
  • Sufficient command of Dutch language.

排除标准

  • The inability to give informed consent;
  • Too ill to participate;
  • Concurrent participation in another questionnaire study on quality of
  • life/psychological functioning.

研究者

发起方
niversitair Medisch Centrum

相似试验